These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1305 related items for PubMed ID: 19821400
1. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. Chin J, Konje JC, Hickey M. Cochrane Database Syst Rev; 2009 Oct 07; (4):CD007245. PubMed ID: 19821400 [Abstract] [Full Text] [Related]
2. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. Dominick S, Hickey M, Chin J, Su HI. Cochrane Database Syst Rev; 2015 Dec 09; 2015(12):CD007245. PubMed ID: 26649916 [Abstract] [Full Text] [Related]
3. Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. Romero SA, Young K, Hickey M, Su HI. Cochrane Database Syst Rev; 2020 Dec 21; 12(12):CD007245. PubMed ID: 33348436 [Abstract] [Full Text] [Related]
4. Long-term effects of levonorgestrel-releasing intrauterine system on tamoxifen-treated breast cancer patients: a meta-analysis. Fu Y, Zhuang Z. Int J Clin Exp Pathol; 2014 Dec 21; 7(10):6419-29. PubMed ID: 25400720 [Abstract] [Full Text] [Related]
5. The efficacy of levonorgestrel intrauterine systems for endometrial protection: a systematic review. Wan YL, Holland C. Climacteric; 2011 Dec 21; 14(6):622-32. PubMed ID: 22017273 [Abstract] [Full Text] [Related]
6. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia. Mittermeier T, Farrant C, Wise MR. Cochrane Database Syst Rev; 2020 Sep 06; 9(9):CD012658. PubMed ID: 32909630 [Abstract] [Full Text] [Related]
7. A randomised controlled trial of prophylactic levonorgestrel intrauterine system in tamoxifen-treated women. Chan SS, Tam WH, Yeo W, Yu MM, Ng DP, Wong AW, Kwan WH, Yuen PM. BJOG; 2007 Dec 06; 114(12):1510-5. PubMed ID: 17995495 [Abstract] [Full Text] [Related]
11. The role of levonorgestrel-releasing intrauterine system for endometrial protection in women with breast cancer taking tamoxifen. Shi Q, Li J, Li M, Wu J, Yao Q, Xing A. Eur J Gynaecol Oncol; 2014 Dec 06; 35(5):492-8. PubMed ID: 25423691 [Abstract] [Full Text] [Related]
12. Prevention of tamoxifen induced endometrial polyps using a levonorgestrel releasing intrauterine system long-term follow-up of a randomised control trial. Gardner FJ, Konje JC, Bell SC, Abrams KR, Brown LJ, Taylor DJ, Habiba M. Gynecol Oncol; 2009 Sep 06; 114(3):452-6. PubMed ID: 19576623 [Abstract] [Full Text] [Related]
13. Levonorgestrel-releasing intrauterine system for atypical endometrial hyperplasia. Luo L, Luo B, Zheng Y, Zhang H, Li J, Sidell N. Cochrane Database Syst Rev; 2013 Jun 05; (6):CD009458. PubMed ID: 23737032 [Abstract] [Full Text] [Related]
18. Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials. Abu Hashim H, Ghayaty E, El Rakhawy M. Am J Obstet Gynecol; 2015 Oct 05; 213(4):469-78. PubMed ID: 25797236 [Abstract] [Full Text] [Related]